Why Avid Bioservices

Avid Bioservices® was established to provide highly specialized cell culture, process development and cGMP manufacturing services for the biotechnology and biopharmaceutical industries utilizing mammalian cell culture. Our manufactuing expertise spans from clinical to commmercial production, including commercial API production since 2005.

Utilizing our core strengths, we will focus on three innovative biopharmaceutical segments: monoclonal antibodies, recombinant proteins and enzymes. We have the experience, facilities and capabilities to manufacture under cGMP, test and characterize your biologics. Our focus is on customers who require 22.5 Liter to 1,000 Liter scale quantities of biologics. Application of fed-batch or perfusion technologies can be used to extend the manufacturing cycle and thereby increase total yield per bioreactor run.

AVID has an experienced team in process sciences, scale-up and manufacturing of complex biologicals from Pre-clinical to Phase III and conformance lots.
AVID's manufacturing capacity is ideally suited for small to mid-sized disease states.
AVID excels at providing services to small and mid-sized biotechnology companies.
AVID limits the facility to antibodies and other recombinant proteins produced in mammalian cells.
AVID offers flexible manufacturing schedules and several modes of production i.e. batch, fed-batch and perfusion.
AVID has already established an excellent reputation.
AVID, while having been founded only a few short years ago, has passed a number of significant regulatory hurdles that we would be glad to review with you.